{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:38Z","timestamp":1707524438900},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,15]]},"DOI":"10.7759\/cureus.18801","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T21:40:33Z","timestamp":1634334033000},"source":"Crossref","is-referenced-by-count":1,"title":["Variety of Cardiac Events in Hospitalized Chronic Kidney Disease Patients"],"prefix":"10.7759","author":[{"given":"Asfia","family":"Jabbar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruqaya","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murtaza","family":"Dhrolia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aasim","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Addressing the global burden of chronic kidney disease through clinical and translational research","volume":"125","author":"Ojo A","year":"2014","unstructured":"Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research. Trans Am Clin Climatol Assoc. 2014, 125:229-43.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go AS","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351:1296-305. 10.1056\/NEJMoa041031","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090765","article-title":"High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination","volume":"16","author":"Ohtake T","year":"2005","unstructured":"Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, Saito S. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol. 2005, 16:1141-8. 10.1681\/ASN.2004090765","journal-title":"J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli M","year":"2006","unstructured":"Tonelli M, Wiebe N, Culleton B, et al.. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006, 17:2034-47. 10.1681\/ASN.2005101085","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00838.x","article-title":"Level of kidney function as a risk factor for cardiovascular outcomes in the elderly","volume":"63","author":"Manjunath G","year":"2003","unstructured":"Manjunath G, Tighiouart H, Coresh J, et al.. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int. 2003, 63:1121-9. 10.1046\/j.1523-1755.2003.00838.x","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1177\/039139880102401004","article-title":"Uremic toxicity: present state of the art","volume":"24","author":"Vanholder R","year":"2001","unstructured":"Vanholder R, Argil\u00e9s A, Baurmeister U, et al.. Uremic toxicity: present state of the art. Int J Artif Organs. 2001, 24:695-725.","journal-title":"Int J Artif Organs"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"National Cholesterol Education Program (US). Expert Panel on Detection, Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III).. (2002). http.\/\/www.aefa.es\/wp-content\/uploads\/2014\/04\/NECP-guidelines-.pdf.","DOI":"10.1001\/jama.285.19.2486"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster AC","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic kidney disease. Lancet. 2017, 389:1238-52. 10.1016\/S0140-6736(16)32064-5","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2004.11.003","article-title":"Traditional and nontraditional cardiovascular risk factors in chronic kidney disease","volume":"89","author":"Vlagopoulos PT","year":"2005","unstructured":"Vlagopoulos PT, Sarnak MJ. Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med Clin North Am. 2005, 89:587-611. 10.1016\/j.mcna.2004.11.003","journal-title":"Med Clin North Am"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61272-0","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis","volume":"380","author":"Mahmoodi BK","year":"2012","unstructured":"Mahmoodi BK, Matsushita K, Woodward M, et al.. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet. 2012, 380:1649-61. 10.1016\/S0140-6736(12)61272-0","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2008.02.002","article-title":"Anti-inflammatory agents and antioxidants as a possible \"third great wave\" in cardiovascular secondary prevention","volume":"101","author":"Bhatt DL","year":"2008","unstructured":"Bhatt DL. Anti-inflammatory agents and antioxidants as a possible \"third great wave\" in cardiovascular secondary prevention. Am J Cardiol. 2008, 101:4D-13D. 10.1016\/j.amjcard.2008.02.002","journal-title":"Am J Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000351758","article-title":"Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease","volume":"38","author":"Moradi H","year":"2013","unstructured":"Moradi H, Sica DA, Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013, 38:136-48. 10.1159\/000351758","journal-title":"Am J Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666141230114500","article-title":"Indoxyl sulfate: a candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease","volume":"16","author":"Barisione C","year":"2015","unstructured":"Barisione C, Ghigliotti G, Canepa M, Balbi M, Brunelli C, Ameri P. Indoxyl sulfate: a candidate target for the prevention and treatment of cardiovascular disease in chronic kidney disease. Curr Drug Targets. 2015, 16:366-72. 10.2174\/1389450116666141230114500","journal-title":"Curr Drug Targets"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.05780612","article-title":"Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality","volume":"8","author":"Vashistha T","year":"2013","unstructured":"Vashistha T, Kalantar-Zadeh K, Molnar MZ, Torl\u00e9n K, Mehrotra R. Dialysis modality and correction of uremic metabolic acidosis: relationship with all-cause and cause-specific mortality. Clin J Am Soc Nephrol. 2013, 8:254-64. 10.2215\/CJN.05780612","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diseases4040036","article-title":"Association between low serum bicarbonate concentrations and cardiovascular disease in patients in the end-stage of renal disease","volume":"4","author":"Raikou VD","year":"2016","unstructured":"Raikou VD, Kyriaki D.  Association between low serum bicarbonate concentrations and cardiovascular disease in patients in the end-stage of renal disease. Diseases. 2016, 4:36. 10.3390\/diseases4040036","journal-title":"Diseases"},{"key":"ref16","article-title":"Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine","volume":"25","author":"Bright R","year":"1836","unstructured":"Bright R. Cases and observations illustrative of renal disease accompanied with the secretion of albuminous urine. Med Chir Rev. 1836, 25:23-35.","journal-title":"Med Chir Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197403282901301","article-title":"Accelerated atherosclerosis in prolonged maintenance hemodialysis","volume":"290","author":"Lindner A","year":"1974","unstructured":"Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med. 1974, 290:697-701. 10.1056\/NEJM197403282901301","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2010.06.001","article-title":"Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease","volume":"3","author":"Hakeem A","year":"2010","unstructured":"Hakeem A, Bhatti S, Karmali KN, et al.. Renal function and risk stratification of diabetic and nondiabetic patients undergoing evaluation for coronary artery disease. JACC Cardiovasc Imaging. 2010, 3:734-45. 10.1016\/j.jcmg.2010.06.001","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32835e89ab","article-title":"Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction","volume":"34","author":"Okuyama C","year":"2013","unstructured":"Okuyama C, Nakajima K, Yamasaki Y, Nishimura T. Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction. Nucl Med Commun. 2013, 34:328-32. 10.1097\/MNM.0b013e32835e89ab","journal-title":"Nucl Med Commun"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s12149-019-01361-w","article-title":"The difference of risk factors predicting cardiac events in patients with chronic kidney disease between with and without diabetes","volume":"33","author":"Okuyama C","year":"2019","unstructured":"Okuyama C, Nakajima K, Nakamura S, Nishimura T. The difference of risk factors predicting cardiac events in patients with chronic kidney disease between with and without diabetes. Ann Nucl Med. 2019, 33:532-40. 10.1007\/s12149-019-01361-w","journal-title":"Ann Nucl Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel A","year":"2008","unstructured":"Patel A, MacMahon S, Chalmers J, et al.. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358:2560-72. 10.1056\/NEJMoa0802987","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.960138","article-title":"Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"122","author":"Riddle MC","year":"2010","unstructured":"Riddle MC. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation. 2010, 122:844-6. 10.1161\/CIRCULATIONAHA.110.960138","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000435838","article-title":"Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment","volume":"5","author":"Di Lullo L","year":"2015","unstructured":"Di Lullo L, Gorini A, Russo D, Santoboni A, Ronco C. Left ventricular hypertrophy in chronic kidney disease patients: from pathophysiology to treatment. Cardiorenal Med. 2015, 5:254-66. 10.1159\/000435838","journal-title":"Cardiorenal Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/vhrm.s4822","article-title":"Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis","volume":"5","author":"Rennenberg RJ","year":"2009","unstructured":"Rennenberg RJ, Kessels AG, Schurgers LJ, van Engelshoven JM, de Leeuw PW, Kroon AA. Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009, 5:185-97. 10.2147\/vhrm.s4822","journal-title":"Vasc Health Risk Manag"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009804","article-title":"Risk factors for heart valve calcification in chronic kidney disease","volume":"97","author":"Rong S","year":"2018","unstructured":"Rong S, Qiu X, Jin X, Shang M, Huang Y, Tang Z, Yuan W. Risk factors for heart valve calcification in chronic kidney disease. Medicine. 2018, 97:e9804. 10.1097\/MD.0000000000009804","journal-title":"Medicine"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186665","article-title":"Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound","volume":"12","author":"Valdivielso JM","year":"2017","unstructured":"Valdivielso JM, Betriu A, Martinez-Alonso M, Arroyo D, Bermudez-Lopez M, Fernandez E. Factors predicting cardiovascular events in chronic kidney disease patients. Role of subclinical atheromatosis extent assessed by vascular ultrasound. PLoS One. 2017, 12:e0186665. 10.1371\/journal.pone.0186665","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.4158\/EP171764.APPGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease","volume":"23","author":"Jellinger PS","year":"2017","unstructured":"Jellinger PS, Handelsman Y, Rosenblit PD, et al.. American Association of Clinical Endocrinologists and American College of Endocrinology Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease. Endocr Pract. 2017, 23:1-87. 10.4158\/EP171764.APPGL","journal-title":"Endocr Pract"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1499-3","article-title":"Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"20","author":"Su X","year":"2019","unstructured":"Su X, Yan B, Wang L, Lv J, Cheng H, Chen Y. Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol. 2019, 20:309. 10.1186\/s12882-019-1499-3","journal-title":"BMC Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Badve SV","year":"2011","unstructured":"Badve SV, Roberts MA, Hawley CM, et al.. Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis. J Am Coll Cardiol. 2011, 58:1152-61. 10.1016\/j.jacc.2011.04.041","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2018.03.016","article-title":"Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure","volume":"266","author":"Jang SY","year":"2018","unstructured":"Jang SY, Chae SC, Bae MH, et al.. Effect of renin-angiotensin system blockade in patients with severe renal insufficiency and heart failure. Int J Cardiol. 2018, 266:180-6. 10.1016\/j.ijcard.2018.03.016","journal-title":"Int J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74512-variety-of-cardiac-events-in-hospitalized-chronic-kidney-disease-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:26Z","timestamp":1707507326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74512-variety-of-cardiac-events-in-hospitalized-chronic-kidney-disease-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.18801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,15]]}}}